Nevro Corp at Morgan Stanley Healthcare Conference Transcript
Let's go kick it off here as we progress through the afternoon here. We have snacks outside. They're red M&Ms. We can't really figure out why at a Morgan Stanley blue conference we have red M&Ms, but we're going to figure that out eventually.
My name is David Lewis, medical device analyst here at Morgan Stanley. It's my pleasure to have with me one member of management from Nevro, the CEO, Keith Grossman. We're going to jump right into Q&A.
Questions & Answers
Keith, just given your kind of limited tenure with the company, a lot is happening in a very short time there. Probably just kind of catch us up to date on what was the opportunity as you saw when you took the job? And sort of how has that opportunity progressed in these first kind of few short months you've in the business?
Sure. Well, first
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
